Table 3.
Identification of Bacillus spp. isolates by bioMerieux API 50 CHBa and 16S rRNA sequence analysesb present in the Bacillus-DFM candidate treatment.
| Isolate | API50 CHB |
16S rRNA sequence analysis |
||
|---|---|---|---|---|
| Taxon | % ID | Closest match | % ID | |
| AM1002 | Bacillus subtilis/amyloliquefaciens | 99.2 | Bacillus subtilis | 100.0 |
| AM0938 | Bacillus subtilis/amyloliquefaciens | 99.0 | Bacillus amyloliquefaciens | 99.7 |
| JD17 | Bacillus subtilis/amyloliquefaciens | 99.4 | Bacillus amyloliquefaciens | 99.6 |
aBioMerieux API 50 CHB test kit.
b16S rRNA sequence analysis.